{"id":"https://openalex.org/W2280923005","doi":"https://doi.org/10.1182/blood.v122.21.1506.1506","title":"A Phase II Clinical Trial Of Lenalidomide and Prednisone In Low and Intermediate-1 IPSS Risk, Non-Del (5q) MDS Patients","display_name":"A Phase II Clinical Trial Of Lenalidomide and Prednisone In Low and Intermediate-1 IPSS Risk, Non-Del (5q) MDS Patients","publication_year":2013,"publication_date":"2013-11-15","ids":{"openalex":"https://openalex.org/W2280923005","doi":"https://doi.org/10.1182/blood.v122.21.1506.1506","mag":"2280923005"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v122.21.1506.1506","doi":"https://doi.org/10.1182/blood.v122.21.1506.1506","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.1506.1506","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010075752","display_name":"Rami S. Komrokji","orcid":"https://orcid.org/0000-0002-1876-5269","observed_orcids":["https://orcid.org/0000-0002-1876-5269"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rami S Komrokji","raw_affiliation_strings":["Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108542434","display_name":"Najla H. Al Ali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Najla H Al Ali","raw_affiliation_strings":["Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041754278","display_name":"Eric Padron","orcid":"https://orcid.org/0000-0002-4707-7916","observed_orcids":["https://orcid.org/0000-0002-4707-7916"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Padron","raw_affiliation_strings":["Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100413485","display_name":"Ji\u2010Hyun Lee","orcid":"https://orcid.org/0000-0001-6420-5150","observed_orcids":["https://orcid.org/0000-0001-6420-5150","https://orcid.org/0000-0003-0450-2879"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ji-Hyun Lee","raw_affiliation_strings":["Biostatistics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039739509","display_name":"Nancy Hillgruber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Nancy Hillgruber","raw_affiliation_strings":["Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076396878","display_name":"Sara Tinsley","orcid":"https://orcid.org/0000-0003-3012-7398","observed_orcids":["https://orcid.org/0000-0003-3012-7398"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sara Tinsley","raw_affiliation_strings":["Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041443589","display_name":"Jeffrey E. Lancet","orcid":"https://orcid.org/0000-0002-7751-7310","observed_orcids":["https://orcid.org/0000-0002-7751-7310"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey E Lancet","raw_affiliation_strings":["Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066001318","display_name":"Alan F. List","orcid":"https://orcid.org/0000-0002-1647-2972","observed_orcids":["https://orcid.org/0000-0002-1647-2972"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan List","raw_affiliation_strings":["H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5039739509","https://openalex.org/A5100413485","https://openalex.org/A5108542434"],"corresponding_institution_ids":["https://openalex.org/I3019308854"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.475,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.71656406,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"122","issue":"21","first_page":"1506","last_page":"1506"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.9919999837875366},{"id":"https://openalex.org/keywords/prednisone","display_name":"prednisone","score":0.9980000257492065},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9160000085830688},{"id":"https://openalex.org/keywords/erythropoietin-receptor-signaling","display_name":"erythropoietin receptor signaling","score":0.8069999814033508},{"id":"https://openalex.org/keywords/erythroid-response","display_name":"erythroid response","score":0.6800000071525574},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.593999981880188},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.7360000014305115},{"id":"https://openalex.org/keywords/erythropoietin","display_name":"erythropoietin","score":0.5630000233650208},{"id":"https://openalex.org/keywords/anemia-management","display_name":"anemia management","score":0.4399999976158142},{"id":"https://openalex.org/keywords/phase-ii-trial-design","display_name":"phase II trial design","score":0.5}],"concepts":[{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.8047022819519043},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7512881755828857},{"id":"https://openalex.org/C2780240888","wikidata":"https://www.wikidata.org/wiki/Q6052586","display_name":"International Prognostic Scoring System","level":4,"score":0.6324827671051025},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.594525933265686},{"id":"https://openalex.org/C2778534260","wikidata":"https://www.wikidata.org/wiki/Q218706","display_name":"Erythropoietin","level":2,"score":0.5469191670417786},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.5382065773010254},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.4712177813053131},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.46329841017723083},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.4213111698627472},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38415175676345825},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.27087217569351196},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.15457558631896973}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v122.21.1506.1506","doi":"https://doi.org/10.1182/blood.v122.21.1506.1506","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.1506.1506","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.5199999809265137,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2907930551","https://openalex.org/W2794722845","https://openalex.org/W2245766358","https://openalex.org/W4235278518","https://openalex.org/W2137166832","https://openalex.org/W2615871811","https://openalex.org/W2556189691","https://openalex.org/W2236991441","https://openalex.org/W2590746929","https://openalex.org/W2559862183"],"abstract_inverted_index":{"Abstract":[0],"Introduction":[1],"Anemia":[2],"remains":[3],"the":[4,28,89,143,165,188,195,198,415,518],"most":[5,424,473],"common":[6,425,474],"management":[7],"challenge":[8],"for":[9,32,227,276,309,476],"patients":[10,134,170,509],"(pts)":[11],"with":[12,37,122,135,148,194,278,496,510],"lower":[13,33,138,513],"risk":[14,34,139,514],"MDS":[15,35,66,140,210,515],"(Low":[16],"and":[17,95,109,124,265,346,455,468,490,498],"int-1":[18,214],"International":[19],"prognostic":[20],"Scoring":[21],"System":[22],"(IPSS)":[23],"groups).":[24],"Lenalidomide":[25],"(LEN)":[26],"is":[27],"treatment":[29,121,495],"of":[30,44,91,179,225,274,349,359,372,382,394,412,434,485,553],"choice":[31],"pts":[36,45,331,527],"chromosome":[38],"5":[39,303,383],"deletion":[40],"(del5q)":[41],"where":[42],"67%":[43],"on":[46],"MDS-003":[47],"study":[48,58,154,189,431,477],"became":[49,354],"red":[50],"blood":[51],"cell":[52],"transfusion":[53],"independence":[54],"(RBC-TI).":[55],"The":[56,153,271,314,340,361,369,423,472],"MDS-002":[57,533],"reported":[59],"26%":[60],"RBC":[61,216,355],"TI":[62,356],"rate":[63,132,342,507],"in":[64,73,96,133,338,508,526,555],"non-del5q":[65,74],"pts.":[67],"Strategies":[68],"to":[69,82,102,142,172,302,364,403,430,517,532,539],"optimize":[70],"LEN":[71,103,123,149,275,497,520,540],"responses":[72],"include":[75],"identifying":[76],"predictive":[77],"biomarkers":[78],"or":[79,213,235,246],"combination":[80,120],"strategies":[81],"potentiate":[83],"erythropoietin":[84,106],"receptor":[85],"signaling.":[86],"Dexamethasone":[87],"increases":[88,98],"proliferation":[90],"immature":[92],"erythroid":[93,99,130,183,242,505],"progenitors":[94],"vitro":[97],"progenitor":[100],"sensitivity":[101],"by":[104,296,321],"enhancing":[105],"(EPO)-transcriptional":[107],"response":[108,131,185,319,365,373,481,486,506],"colony":[110],"forming":[111],"capacity":[112],"(BL":[113],"Ebert,":[114],"un-published":[115],"data).":[116],"We":[117],"hypothesize":[118],"that":[119,197],"prednisone":[125,499],"will":[126,190],"yield":[127,502],"a":[128,279,408,503],"higher":[129,504],"non-del":[136,511],"(5q)":[137,512],"compared":[141,516,531],"historical":[144,519],"clinical":[145],"trial":[146],"experience":[147],"monotherapy":[150],"(MT).":[151,541],"Methods":[152],"was":[155,283,288,317,343,366,374,418,537],"an":[156],"investigator":[157],"initiated":[158],"two-":[159],"step":[160,167],"phase":[161],"II":[162],"design.":[163],"In":[164],"first":[166],"25":[168,181,413],"eligible":[169],"were":[171,332,479],"be":[173,191],"registered.":[174],"If":[175],"fewer":[176],"than":[177],"4":[178],"these":[180],"achieved":[182],"hematological":[184],"(HI-E),":[186],"then":[187],"terminated":[192],"early":[193],"conclusion":[196],"regimen":[199],"does":[200],"not":[201,386,419,501],"warrant":[202],"further":[203],"investigation.":[204],"Key":[205],"eligibility":[206],"criteria":[207,324],"included":[208,461],"confirmed":[209],"diagnosis,":[211],"low":[212],"IPSS,":[215],"transfusion-dependent":[217],"anemia":[218,237,441,462],"defined":[219],"as":[220],"having":[221],"received":[222,397,529],"\u22654":[223],"transfusions":[224],"RBCs":[226],"Hgb":[228],"\u2264":[229,239],"9.0":[230,240],"g/dl":[231],"within":[232,325],"56":[233],"days":[234,376],"symptomatic":[236],"(Hgb":[238],"g/dl),":[241],"stimulating":[243],"agents":[244],"failure":[245],"endogenous":[247],"serum":[248],"epo":[249],">":[250],"500":[251,258],"mU/ml.,":[252],"absolute":[253],"neutrophil":[254],"count":[255,261],"(ANC)":[256],"\u2265":[257,262,268],"/mm\u2265,":[259,264],"platelet":[260],"50,000":[263],"creatinine":[266],"Clearance":[267],"30":[269,289],"mL/min.":[270],"planned":[272],"dose":[273,287],"subjects":[277],"baseline":[280],"CrCl":[281],">60ml/min":[282],"10":[284,297],"mg/day.":[285],"Prednisone":[286],"mg":[290,298,304],"po":[291,305],"daily":[292],"cycle":[293,301,312],"1":[294],"tapered":[295],"after":[299],"each":[300],"every":[306],"other":[307],"day":[308],"responders":[310,353,384],"beyond":[311],"6.":[313],"primary":[315],"objective":[316],"best":[318],"(HI-E)":[320],"IWG":[322],"2006":[323],"24":[326],"weeks.":[327],"Results":[328],"Twenty":[329],"five":[330],"enrolled.":[333],"Baseline":[334],"characteristics":[335],"are":[336,524],"summarized":[337],"table-1.":[339],"HI-E":[341,522],"20%":[344],"(5/25),":[345],"22%":[347],"(5/23)":[348],"evaluable":[350],"patients.":[351],"All":[352],"(5":[357],"out":[358,381,393],"23).":[360],"median":[362,370,409,416],"time":[363],"57":[367],"days.":[368],"duration":[371],"80":[375],"(95%":[377],"CI":[378],"69-91).":[379],"Three":[380],"did":[385,500],"have":[387],"hypomethylating":[388],"agent":[389],"(HMA)":[390],"while":[391],"14":[392],"20":[395],"non-responders":[396],"prior":[398],"HMA.":[399],"No":[400],"patient":[401],"transformed":[402],"acute":[404],"myeloid":[405],"leukemia.":[406],"At":[407],"follow":[410],"up":[411],"months":[414],"OS":[417],"reached":[420],"(2":[421],"deaths).":[422],"adverse":[426],"events":[427,460],"deemed":[428],"related":[429],"drug":[432],"(>10%":[433],"pts)":[435],"included,":[436],"neutropenia":[437,464],"54%,":[438],"thrombocytopenia":[439,466],"40%,":[440],"32%,":[442],"diarrhea":[443],"27%,":[444],"myalgia":[445],"20%,":[446,450],"edema":[447],"24%,":[448],"rash":[449,491],"infection":[451,488],"12%,":[452,454],"fever":[453],"fatigue":[456],"12%.":[457],"Grade":[458],"III/IV":[459],"(n=8),":[463],"(n=4),":[465],"(n=3),":[467],"Cerebrovascular":[469],"event":[470],"(n=1).":[471],"causes":[475],"discontinuation":[478],"no":[480],"(10":[482],"pts),":[483],"loss":[484],"(4pts),":[487],"(4pts)":[489],"(4pts).":[492],"Conclusion":[493],"Combination":[494],"MT.":[521],"rates":[523],"less":[525],"who":[528],"HMA":[530],"study.":[534],"Toxicity":[535],"profile":[536],"similar":[538],"Disclosures:":[542],"Komrokji:":[543],"Celgene:":[544],"Research":[545,560,563],"Funding,":[546],"Speakers":[547],"Bureau.":[548],"Off":[549],"Label":[550],"Use:":[551],"use":[552],"lenalidomide":[554],"non":[556],"del":[557],"5q.":[558],"Lancet:Celgene:":[559],"Funding.":[561,564],"List:Celgene:":[562]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}